Market Highlights: Market Research Future (MRFR) observed that the emerging class of proteomic technologies, the protein microarray is growing to be an essential aid in molecular biology and biochemistry. The report published by MRFR, on the global protein microarray market forecasts that the market will register an impressive CAGR of about 8.2% from 2017 to 2023. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5310 The protein microarray technology, which potentially overcame the limitation of DNA microarray techniques is expected to reinforce the global protein microarray market growth. Also, referred to as protein chips, protein microarray has numerous applications. It is used for antibody characterization, analysis of protein functions, and as proteomics are surging its adoption among different healthcare organizations. Additionally, the utility of protein microarray in diagnosis and treatment are likely to note an accelerated popularity of protein microarray. Hence, amplification in the growth of the Protein Microarray Market is expected. Despite the presence of strong market drivers, the high sensitivity of protein to environmental changes can hinder the protein microarray market growth. The limitation for providing a suitable condition for the storage of protein can decline the market growth. Key Players:PerkinElmer Inc., Sigma Aldrich Corporation,Thermo Fisher Scientific, Agilent Technologies, Fluidigm Corporation, GE Healthcare, Affymetrix, Inc., SEQUENOM, Inc., EMD Millipore,Abbott Laboratories, Angioscore Ltd. Bio-Rad Laboratories Inc.,Illumina Inc., Medtronic Inc.,and Cepheid Inc
Segmental Overview:
Regional Study and Key Players: The Americas, Asia Pacific, Europe, and the Middle East and Africa are the regional subjects for the protein microarray marketstudy. MRFR predicts that due to the well-built healthcare infrastructure in the Americas, the regional market is expected to grasp the largest share of the global protein microarray market. In 2017, the American Cancer Society revealed that around 16, 88,780 new cases of cancer were diagnosed.This demonstrates that the surging cases of cancer can spur the regional market growth. The revenue generated by the protein microarraymarket is impressive. It was recorded that the national expenditure of the US on cancer management was approximately USD 125 billion, which can escalate up to USD 156 billion by 2020. Hence, the hike in medical expenses can prompt the American market growth. Access Full Report Details @ https://www.marketresearchfuture.com/reports/protein-microarray-market-5310 In Europe, the rise in number of research and developmental undertakings by eminent pharmaceuticals and biotechnology companies for designing effective drugs is observed. Hence,Europe is projected to secure the second-largest share of the global protein microarray treatment market. The changing lifestyle is also anticipated to reinforce the European protein microarray market growth. Genentech, a division of F. Hoffmann-La Roche AG, in Switzerland, is a prominent company existing in Europe. The Asia Pacific region accounted for the fast-paced market growth over the assessment period. The surge in government funding, spreading awareness about personalized medicine, increase in prevalence cancer are factors, which are promoting adoption of protein chips among in APAC. Hence, the accelerated popularity of protein microarray in strong economies like India and China is expected to amplify the regional market growth. The Middle East and African market is likely to boom over the review period. The hike in investments made by the market key players and surging adoption of protein microarrays as a diagnostic aid are anticipated to propel the regional market expansion.